BioStock: DanCann Pharma’s CEO on the new milestone

DanCann Pharma has completed its first successful production run of biomaterial in its recently fully established production facilities, an achievement CEO Jeppe Krog Rasmussen calls a significant milestone towards the final approval of the facilities for production of cannabis biomaterial. BioStock reached out to Krog Rasmussen for a comment.  

Read the full interview with Jeppe Krog Rasmussen at biostock.se:

https://www.biostock.se/en/dancann-pharmas-ceo-on-the-new-milestone/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/